National Taiwan University Hospital: Neoplasm Metastasis trials

The registry lists 27 Neoplasm Metastasis studies with National Taiwan University Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 1No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone MetastasisNot yet recruitingNCT06604910Not applicable
• Non-small Cell Lung Cancer With Central Nervous System MetastasisRecruitingNCT06026735
• Short Versus Long Intramedullary Nails in the Treatment of Proximal Femur Metastasis.Not yet recruitingNCT05969470Not applicable
• Post Operative RT for Limited Spine MetastasesRecruitingNCT05495399Not applicable
• The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)CompletedNCT06424210
• Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain MetastasesStatus unknownNCT04801342Phase 2
• CT-DSA Evaluation of Embolization in Debulking Spinal SurgeryCompletedNCT04497051
• A Prospective Randomized Trial of High Dose Versus Standard Dose Stereotactic Radiotherapy for Pain Control in Patients With Bone MetastasesStatus unknownNCT04063254Phase 2
• Involved Versus Elective Target SSRS for Spinal MetastasesStatus unknownNCT04033536Not applicable
• Evaluation of Spinal Metastatic Tumour for Aggressive Spinal Sugery by Dual Energy CTCompletedNCT03631095
• Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver MetastasisCompletedNCT03264716Not applicable
• Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival RateStatus unknownNCT02934594
• A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic LymphadenopathyStatus unknownNCT02803151Not applicable
• Single Versus Multiple Fractionated SSRS for Spinal MetastasesStatus unknownNCT02608866Not applicable
• Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain MetastasesStatus unknownNCT02393131Not applicable
• Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesStatus unknownNCT02185352Phase 2
• 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.Status unknownNCT01927939
• The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric CancerStatus unknownNCT01627119
• Vorinostat and Concurrent Whole Brain Radiotherapy for Brain MetastasisTerminatedNCT01600742Phase 2
• Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
• Retrospective Study of Ovarian Cancer Patients With Brain MetastasisStatus unknownNCT01258881
• Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic DiseaseStatus unknownNCT00792896Not applicable
• Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 TherapyStatus unknownNCT00610636Phase 3
• The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell CarcinomaStatus unknownNCT00174096
• Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal CancersStatus unknownNCT00172159Phase 2
• Molecular Mechanism of Trophinin in Cancer Invasion and MetastasisCompletedNCT00166972
• Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary HypertensionWithdrawnNCT00155714Not applicable